NCT07678671Enrolling by invitation
Glycemic Control and the Ask Me 3® Educational Program
Difference in Glycemic Control Among Patients With Type 2 Diabetes Mellitus Receiving the Ask Me 3® Educational Program: A 3-Month Follow-Up Study
Source: ClinicalTrials.gov · Last updated 17 Sept 2026
Brief summary (registry, in English)
The goal of this clinical trial is to determine whether the Ask Me 3® educational program improves glycemic control in adults with type 2 diabetes mellitus receiving care at a metabolic clinic. The main questions it aims to answer are: Does participation in the Ask Me 3® educational program improve glycated hemoglobin (HbA1c) and fasting plasma glucose levels after a 3-month follow-up? Researchers will compare participants who receive the Ask Me 3® educational program with those who receive standard medical care alone to determine whether the educational intervention improves glycemic control. Participants will: Provide written informed consent and undergo eligibility assessment. Be randomly assigned to either the intervention group or the control group. Complete baseline assessments, including demographic information, anthropometric measurements, medical history, dietary habits, physical activity, diabetes education, and nutritional counseling history. Have baseline HbA1c and fasting plasma glucose values collected from their medical records. Receive either the Ask Me 3® educational program (intervention group) or standard care (control group). Attend routine follow-up visits over a 3-month period. Complete a final evaluation, including repeat clinical measurements and collection of HbA1c and fasting plasma glucose values to assess changes in glycemic control.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 10 Jun 2026
- Start date
- 5 Jun 2025
- Primary completion date
- 31 Oct 2026
- Lead sponsor
- Maria Elena Romero Ibarguengoitia
- Diseases
- Type 2 diabetes
- NCT number
- NCT07678671
What you commit to
- Study type: Interventional
- Planned participants: 250
- From 5 Jun 2025 to the primary completion date, 31 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving palliative care.
Other illness
- Patients with autoimmune, immunological, or oncological comorbidities.
- Patients with cognitive or psychiatric conditions that impair their ability to provide informed consent independently (e.g., delirium, schizophrenia, or similar conditions).
Other
- Pregnant women.
Who the study is looking for
- Adults aged 18 years or older.
- Beneficiaries of Hospital Clínica Nova.
- Male and female participants.
- Confirmed diagnosis of type 2 diabetes mellitus according to the institution's established clinical practice guidelines.
- Patients receiving care at the Metabolic Clinic.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Clinica Nova de Monterrey Coordinator of this site? Confirm its status | San Nicolás de los Garza | Mexico | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.